0 items USD 0.00Search
- Did you mean
- general drugs
Your search for "Generic Drugs" gave back 80672 results.
Tigecycline is an antibiotic for a number of bacterial infections. It is a glycylcycline administered intravenously. It was developed in response to...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
The global Pain Management Drugs market size is predicted to grow from US$ 38030 million in 2025 to US$ 46540 million in 2031; it is expected to grow...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
The global Ampicillin Injection market size is predicted to grow from US$ 1785 million in 2025 to US$ 2376 million in 2031; it is expected to grow at...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
The global market for Pharmaceutical Grade Paliperidone was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
Mifamurtide is a drug against osteosarcoma, a kind of bone cancer mainly affecting children and young adults, which is lethal in about a third of...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
Lisdexamfetamine dimesylate generics are medications that contain the same active ingredient, lisdexamfetamine, as the brand-name drug. These...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 2,900.00
Glatiramer is an immunomodulator medication currently used to treat multiple sclerosis. The global Glatiramer Drugs market was valued at US$ 1072...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
Fingolimod hydrochloride generic is an alternative to the brand-name drug used to treat relapsing forms of multiple sclerosis (MS). This medication...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 2,900.00
The global Rare Disease Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Rare Disease Treatment...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
Myelodysplastic syndrome is caused by mutation of one or more genes that control development of blood cells. It is one of the most common malignant...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The global market for Methotrexate Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031...
颁补迟补濒辞驳:听
MRRPB5
February 2025
Price: USD 2,900.00
The global Chiral Non-Heterocyclic Building Blocks market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million...
颁补迟补濒辞驳:听
GIR
March 2024
Price: USD 3,480.00
The global Non-Heterocyclic Fluorinated Building Blocks market size was valued at USD million in 2023 and is forecast to a readjusted size of USD...
颁补迟补濒辞驳:听
GIR
March 2024
Price: USD 3,480.00
听
